282 related articles for article (PubMed ID: 10199770)
1. Growth hormone (GH) therapy in GH-deficient adults influences the response to a dietary load of cholesterol and saturated fat in terms of cholesterol synthesis, but not serum low density lipoprotein cholesterol levels.
Leonsson M; Oscarsson J; Bosaeus I; Lundgren BK; Johannsson G; Wiklund O; Bengtsson BA
J Clin Endocrinol Metab; 1999 Apr; 84(4):1296-303. PubMed ID: 10199770
[TBL] [Abstract][Full Text] [Related]
2. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.
Cuneo RC; Judd S; Wallace JD; Perry-Keene D; Burger H; Lim-Tio S; Strauss B; Stockigt J; Topliss D; Alford F; Hew L; Bode H; Conway A; Handelsman D; Dunn S; Boyages S; Cheung NW; Hurley D
J Clin Endocrinol Metab; 1998 Jan; 83(1):107-16. PubMed ID: 9435425
[TBL] [Abstract][Full Text] [Related]
3. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group.
Attanasio AF; Lamberts SW; Matranga AM; Birkett MA; Bates PC; Valk NK; Hilsted J; Bengtsson BA; Strasburger CJ
J Clin Endocrinol Metab; 1997 Jan; 82(1):82-8. PubMed ID: 8989238
[TBL] [Abstract][Full Text] [Related]
4. Low dose continuously infused growth hormone results in increased lipoprotein(a) and decreased low density lipoprotein cholesterol concentrations in middle-aged men.
Oscarsson J; Ottosson M; Wiklund O; Mårin P; Vikman-Adolfsson K; Björntorp P; Edén S
Clin Endocrinol (Oxf); 1994 Jul; 41(1):109-16. PubMed ID: 8050123
[TBL] [Abstract][Full Text] [Related]
5. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G
J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of saturated fat and cholesterol intakes on serum lipids: Tehran Lipid and Glucose Study.
Mirmiran P; Ramezankhani A; Azizi F
Nutrition; 2009 May; 25(5):526-31. PubMed ID: 19121920
[TBL] [Abstract][Full Text] [Related]
7. Isocaloric substitution of plant sterol-enriched fat spread for carbohydrate-rich foods in a low-fat, fibre-rich diet decreases plasma low-density lipoprotein cholesterol and increases high-density lipoprotein concentrations.
Skeaff CM; Thoma C; Mann J; Chisholm A; Williams S; Richmond K
Nutr Metab Cardiovasc Dis; 2005 Oct; 15(5):337-44. PubMed ID: 16216719
[TBL] [Abstract][Full Text] [Related]
8. Variability in response to a low-fat, low-cholesterol diet in children with elevated low-density lipoprotein cholesterol levels.
Quivers ES; Driscoll DJ; Garvey CD; Harris AM; Harrison J; Huse DM; Murtaugh P; Weidman WH
Pediatrics; 1992 May; 89(5 Pt 1):925-9. PubMed ID: 1579405
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol absorption and synthesis related to low density lipoprotein metabolism during varying cholesterol intake in men with different apoE phenotypes.
Gylling H; Miettinen TA
J Lipid Res; 1992 Sep; 33(9):1361-71. PubMed ID: 1402403
[TBL] [Abstract][Full Text] [Related]
10. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children.
Johannsson G; Albertsson-Wikland K; Bengtsson BA
J Clin Endocrinol Metab; 1999 Dec; 84(12):4516-24. PubMed ID: 10599711
[TBL] [Abstract][Full Text] [Related]
11. The effect of replacing dietary saturated fat with polyunsaturated or monounsaturated fat on plasma lipids in free-living young adults.
Hodson L; Skeaff CM; Chisholm WA
Eur J Clin Nutr; 2001 Oct; 55(10):908-15. PubMed ID: 11593354
[TBL] [Abstract][Full Text] [Related]
12. Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women.
Matthan NR; Welty FK; Barrett PH; Harausz C; Dolnikowski GG; Parks JS; Eckel RH; Schaefer EJ; Lichtenstein AH
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1092-7. PubMed ID: 15087307
[TBL] [Abstract][Full Text] [Related]
13. A nine-month, placebo-controlled study of the effects of growth hormone treatment on lipoproteins and LDL size in abdominally obese men.
Svensson J; Bengtsson BA; Taskinen MR; Wiklund O; Johannsson G
Growth Horm IGF Res; 2000 Jun; 10(3):118-26. PubMed ID: 10942632
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy.
Monson JP; Jönsson P; Koltowska-Häggström M; Kourides I
Clin Endocrinol (Oxf); 2007 Oct; 67(4):623-8. PubMed ID: 17581260
[TBL] [Abstract][Full Text] [Related]
15. Effects of a low-fat diet on plasma lipoprotein levels.
Sacks FM; Handysides GH; Marais GE; Rosner B; Kass EH
Arch Intern Med; 1986 Aug; 146(8):1573-7. PubMed ID: 3729638
[TBL] [Abstract][Full Text] [Related]
16. Dietary fat intake, body composition and blood lipids of university men and women.
Neville MM; Geppert J; Min Y; Grimble G; Crawford MA; Ghebremeskel K
Nutr Health; 2012 Jul; 21(3):173-85. PubMed ID: 23533205
[TBL] [Abstract][Full Text] [Related]
17. The favourable effects of growth hormone (GH) substitution on hypercholesterolaemia in GH-deficient adults are not associated with concomitant reductions in adiposity. A 12 month placebo-controlled study.
Vahl N; Jørgensen JO; Hansen TB; Klausen IB; Jurik AG; Hagen C; Christiansen JS
Int J Obes Relat Metab Disord; 1998 Jun; 22(6):529-36. PubMed ID: 9665673
[TBL] [Abstract][Full Text] [Related]
18. Effects of exercise, dietary cholesterol, and dietary fat on blood lipids.
Johnson C; Greenland P
Arch Intern Med; 1990 Jan; 150(1):137-41. PubMed ID: 2297284
[TBL] [Abstract][Full Text] [Related]
19. Effects of phytosterol ester-enriched low-fat milk on serum lipoprotein profile in mildly hypercholesterolaemic patients are not related to dietary cholesterol or saturated fat intake.
Hernández-Mijares A; Bañuls C; Rocha M; Morillas C; Martínez-Triguero ML; Víctor VM; Lacomba R; Alegría A; Barberá R; Farré R; Lagarda MJ
Br J Nutr; 2010 Oct; 104(7):1018-25. PubMed ID: 20456813
[TBL] [Abstract][Full Text] [Related]
20. Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins, but not lipoprotein(a).
Svensson J; Jansson JO; Ottosson M; Johannsson G; Taskinen MR; Wiklund O; Bengtsson BA
J Clin Endocrinol Metab; 1999 Jun; 84(6):2028-33. PubMed ID: 10372705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]